Rankings
▼
Calendar
JAZZ FY 2015 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena
JAZZ
Jazz Pharmaceuticals plc
$11B
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.3B
+13.0% YoY
Gross Profit
$1.2B
92.3% margin
Operating Income
$508M
38.4% margin
Net Income
$330M
24.9% margin
EPS (Diluted)
$5.23
Cash Flow
Operating Cash Flow
$532M
Free Cash Flow
$496M
Stock-Based Comp.
$92M
Balance Sheet
Total Assets
$3.4B
Total Liabilities
$1.8B
Stockholders' Equity
$1.6B
Cash & Equivalents
$989M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.3B
$1.2B
+13.0%
Gross Profit
$1.2B
$1.1B
+15.8%
Operating Income
$508M
$196M
+159.8%
Net Income
$330M
$58M
+464.4%
← FY 2014
All Quarters
Q1 2016 →